Abstract:The expanding gene‐editing toolbox has driven a biomedical revolution. These molecular tools tremendously contribute to the progression of fundamental research, such as epigenetics, drug development, disease modeling, and disease diagnosis. Furthermore, therapeutic gene editing offers a profound opportunity to improve the current treatment of human diseases. The expanding genome editing toolbox has revolutionized life science research ranging from the bench to the bedside. These "molecular scissors" have offered us unprecedented abilities to manipulate nucleic acid sequences precisely in living cells from diverse species. Continued advances in genome editing exponentially broaden our knowledge of human genetics, epigenetics, molecular biology, and pathology. Currently, gene editing‐mediated therapies have led to impressive responses in patients with hematological diseases, including sickle cell disease and thalassemia. With the discovery of more efficient, precise and sophisticated gene‐editing tools, more therapeutic gene‐editing approaches will enter the clinic to treat various diseases, such as acquired immunodeficiency sydrome (AIDS), hematologic malignancies, and even severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infection. These initial successes have spurred the further innovation and development of gene‐editing technology. In this review, we will introduce the architecture and mechanism of the current gene‐editing tools, including clustered regularly interspaced short palindromic repeats (CRISPR) and CRISPR‐associated nuclease‐based tools and other protein‐based DNA targeting systems, and we summarize the meaningful applications of diverse technologies in preclinical studies, focusing on the establishment of disease models and diagnostic techniques. Finally, we provide a comprehensive overview of clinical information using gene‐editing therapeutics for treating various human diseases and emphasize the opportunities and challenges.

CRISPR-Cas13: Pioneering RNA Editing for Nucleic Acid Therapeutics

Programmable System of Cas13-Mediated RNA Modification and Its Biological and Biomedical Applications

Insights Gained from RNA Editing Targeted by the CRISPR-Cas13 Family

Development and application of CRISPR/Cas9 technologies in genomic editing.

RNA editing with CRISPR-Cas13

RNA in Therapeutics: CRISPR in the Clinic

Methods for in vitro CRISPR/CasRx-Mediated RNA Editing

Applications and challenges of CRISPR-Cas gene-editing to disease treatment in clinics

Assessing and advancing the safety of CRISPR-Cas tools: from DNA to RNA editing

CRISPR/Cas9 therapeutics: progress and prospects

Programmable RNA targeting with CRISPR-Cas13

Intelligent nanotherapeutic strategies for the delivery of CRISPR system

Chemical Modification and Transformation Strategies of Guide RNAs in CRISPR‐Cas9 Gene Editing Systems

Gene and RNA Editing: Methods, Enabling Technologies, Applications, and Future Directions

Delivery strategies of the CRISPR-Cas9 gene-editing system for therapeutic applications

Precision in Action: The Role of Clustered Regularly Interspaced Short Palindromic Repeats/Cas in Gene Therapies

The Potential of CRISPR/Cas9 Gene Editing as a Treatment Strategy for Inherited Diseases

Recent advances in the delivery and applications of nonviral CRISPR/Cas9 gene editing

Current landscape of gene‐editing technology in biomedicine: Applications, advantages, challenges, and perspectives

CRISPR/Cas: a Nobel Prize award-winning precise genome editing technology for gene therapy and crop improvement

Recent Therapeutic Gene Editing Applications to Genetic Disorders